44 / 56
53.1% of patients
experienced a
decrease from
baseline
–100
–80
–60
–40
–20
0
20
40
60
80
100
Change From Bassline, %
Maximum Change
Asia
Rest of world
•
Total population
•
6-month OS rate: 66%
•
Median OS: 11.4 months (95% CI, 5.7-NR)
OS
0
10
20
30
40
50
60
70
80
90
100
0
2
4
6
8
10 12 14 16
Time, months
Overall Survival, %
n at risk
17
15
12
11
10
8
1
0
0
Asia
19
16
13
11
8
7
6
5
0
ROW
Asia
Rest of world
KEYNOTE-012: Gastric Cancer Cohort
Muro K et al. Lancet Oncol 2016
OR: 22%